Squarepoint’s Stoke Therapeutics STOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $266K | Buy |
+23,458
| New | +$266K | ﹤0.01% | 2220 |
|
|
2025
Q1 | – | Sell |
-120,242
| Closed | -$1.33M | – | 3197 |
|
|
2024
Q4 | $1.33M | Buy |
120,242
+7,575
| +7% | +$83.6K | ﹤0.01% | 1377 |
|
|
2024
Q3 | $1.38M | Buy |
112,667
+97,625
| +649% | +$1.2M | ﹤0.01% | 1292 |
|
|
2024
Q2 | $203K | Sell |
15,042
-36,055
| -71% | -$487K | ﹤0.01% | 2142 |
|
|
2024
Q1 | $690K | Buy |
51,097
+32,001
| +168% | +$432K | ﹤0.01% | 1520 |
|
|
2023
Q4 | $100K | Buy |
19,096
+3,886
| +26% | +$20.4K | ﹤0.01% | 2273 |
|
|
2023
Q3 | $59.9K | Buy |
+15,210
| New | +$59.9K | ﹤0.01% | 2309 |
|
|
2023
Q2 | – | Sell |
-17,851
| Closed | -$149K | – | 2818 |
|
|
2023
Q1 | $149K | Buy |
+17,851
| New | +$149K | ﹤0.01% | 1953 |
|
|
2021
Q3 | – | Sell |
-6,495
| Closed | -$219K | – | 2721 |
|
|
2021
Q2 | $219K | Sell |
6,495
-4,217
| -39% | -$142K | ﹤0.01% | 2166 |
|
|
2021
Q1 | $416K | Buy |
+10,712
| New | +$416K | ﹤0.01% | 1656 |
|
|
2020
Q4 | – | Sell |
-10,837
| Closed | -$363K | – | 2862 |
|
|
2020
Q3 | $363K | Buy |
+10,837
| New | +$363K | ﹤0.01% | 1556 |
|
|
2020
Q1 | – | Sell |
-20,286
| Closed | -$574K | – | 2419 |
|
|
2019
Q4 | $574K | Sell |
20,286
-1,413
| -7% | -$40K | ﹤0.01% | 1647 |
|
|
2019
Q3 | $466K | Buy |
+21,699
| New | +$466K | ﹤0.01% | 1599 |
|